Barriers to better care for people with AIDS in developing countries
BMJ 2005; 330 doi: https://doi.org/10.1136/sbmj.050130 (Published 01 January 2005) Cite this as: BMJ 2005;330:050130
- Andrew S Furber, clinical lecturer in public health1,
- Ian J Hodgson, lecturer2,
- Alice Desclaux, professor of medical anthropology3,
- David S Mukasa, HIV and AIDS trainer and counsellor4
- 1Public Health GIS Unit, School for Health and Related Research, University of Sheffield, Sheffield S1 4DA
- 2School of Health Studies, University of Bradford
- 3Centre de Recherche Cultures, Santé, Sociétés, Université d'Aix-Marseille, Maison Méditerranéenne des Sciences de l'Homme, 13 094 Aix en Provence Cedex 2, France
- 4Uganda Red Cross Society, PO Box 494, Kampala, Uganda
Access to good quality antiretroviral treatment has transformed the prognosis for people with AIDS in the developed world. Although it is feasible and desirable to deliver antiretroviral drugs in resource poor settings,1w1w2 few of the 95% of people with HIV and AIDS who live in developing countries receive them. The World Health Organization has launched a programme to deliver antiretroviral drugs to three million people with AIDS in the developing world by 2005, the “3 by 5” initiative.2w3 We identify some of the challenges faced by the initiative, focusing on delivery of care.
Continuum of care
Ideally, care for people with AIDS should start with voluntary counselling and HIV testing. However, only 10% of people who need testing in low and middle income countries have access to services, and therefore most are unaware of their serological status.w5 Care should include psychological, social, and economic support as well as broad based medical care incorporating nutritional advice, prevention and treatment of opportunistic infections, and palliative care.3w6 In many countries, this continuum remains to be set up.
The 3 by 5 initiative considers access to antiretroviral drugs as an opportunity to improve care and enhance prevention efforts.4 However, the focus on antiretroviral drugs risks distracting resources and attention from a broader model of health care. A recent survey of palliative care for people with AIDS in developing countries showed that services were often inadequate.5 Pain management was especially poor. India's decision to rapidly provide free antiretroviral drugs to 100 000 people with AIDS, in the six states with the highest …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.